The American Animal Hospital Association has given the stamp of approval to pet software developer BabelBark and drug maker Kindred Biosciences.
BabelBark became a Preferred Provider, identifying the Newton, Massachusetts, company as a trusted provider of essential business services for AAHA members. San Francisco-based Kindred Bio is an Advantage vendor, part of AAHA’s group purchasing organization.
BabelBark’s BabelVet software platform is designed to help veterinarians monitor patients remotely and communicate with clients through the BabelBark mobile app. The BizBark software platform connects pet owners with service providers.
BabelBark reported being named “the exclusive provider to the American Animal Hospital Association’s more than 4,426 accredited hospitals across Canada and the United States for vet-to-pet health care monitoring and communication applications and services.”
Among more than a dozen other Preferred Providers are CareCredit for client payment options and MWI Animal Health for drugs and supplies.
KindredBio will help fund AAHA’s educational programs and resources. The company’s first FDA-approved drug, Mirataz (mirtazapine transdermal ointment), is formulated for the management of unintended weight loss in cats.
More than 20 companies are Advantage vendors. Among them are Bovie Animal Health, Dechra Veterinary Products and Zoetis.